National Health Investors (NYSE:NHI) Stock Price Expected to Rise, Truist Financial Analyst Says

National Health Investors (NYSE:NHI) had its target price lifted by stock analysts at Truist Financial from $70.00 to $76.00 in a research note issued to investors on Wednesday,Benzinga reports. The firm currently has a “hold” rating on the real estate investment trust’s stock. Truist Financial’s price objective indicates a potential upside of 1.74% from the company’s current price.

Separately, Wedbush reiterated an “outperform” rating and issued a $88.00 price objective on shares of National Health Investors in a research note on Monday. Three analysts have rated the stock with a hold rating and two have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and an average target price of $85.50.

National Health Investors Stock Down 1.1 %

Shares of NYSE NHI opened at $74.70 on Wednesday. The company has a quick ratio of 10.29, a current ratio of 10.29 and a debt-to-equity ratio of 0.92. National Health Investors has a 52 week low of $57.80 and a 52 week high of $86.13. The firm has a 50-day moving average price of $70.22 and a 200 day moving average price of $74.68. The stock has a market capitalization of $3.41 billion, a price-to-earnings ratio of 25.67, a price-to-earnings-growth ratio of 4.42 and a beta of 1.08.

National Health Investors (NYSE:NHI) last announced its quarterly earnings data on Tuesday, February 25th. The real estate investment trust reported $1.13 EPS for the quarter, beating the consensus estimate of $1.10 by $0.03. National Health Investors had a net margin of 38.53% and a return on equity of 10.11%. The firm had revenue of $85.75 million during the quarter, compared to analysts’ expectations of $81.13 million. Equities research analysts anticipate that National Health Investors will post 4.41 EPS for the current fiscal year.

Hedge Funds Weigh In On National Health Investors

Several hedge funds have recently added to or reduced their stakes in NHI. Norges Bank purchased a new stake in shares of National Health Investors during the fourth quarter worth about $42,322,000. Millennium Management LLC grew its holdings in shares of National Health Investors by 1,967.0% during the fourth quarter. Millennium Management LLC now owns 488,353 shares of the real estate investment trust’s stock worth $33,843,000 after buying an additional 464,727 shares in the last quarter. Balyasny Asset Management L.P. purchased a new stake in shares of National Health Investors during the fourth quarter worth about $23,917,000. Marshall Wace LLP grew its holdings in shares of National Health Investors by 161.6% during the fourth quarter. Marshall Wace LLP now owns 551,585 shares of the real estate investment trust’s stock worth $38,225,000 after buying an additional 340,712 shares in the last quarter. Finally, Zimmer Partners LP purchased a new stake in shares of National Health Investors during the third quarter worth about $25,218,000. 62.51% of the stock is currently owned by hedge funds and other institutional investors.

National Health Investors Company Profile

Incorporated in 1991, National Health Investors, Inc (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.